Searched for
GLENMARK SALES GROWTH
These large-caps have ‘strong buy’ & ‘buy’ recos and an upside potential of up to 27%As the market seems to be in comeback mode, it helps to be aware that the best (and probably biggest) wealth creator of the last couple of ...- These large- and mid-cap stocks can give more than 25% return in 1 year, according to analystsThere are market phases when one risk dominates. Then there are phases like this, when risks arrive from every direction and refuse to stan...
- Glenmark Pharma Q2 Results: Co posts Rs 355 crore net profit on robust sales growthGlenmark Pharma reported Rs 340 crore net profit in Q2FY25 led by robust sales growth in India and Europe. The drugmaker reported a net los...
- Glenmark Pharma to sell 75% stake in Glenmark Life to Nirma for Rs 5,652 croreGlenmark Pharmaceuticals will sell 9,18,95,379 shares in the subsidiary at Rs 615 a share. The 75% stake sale in Glenmark Life Sciences wil...
- Glenmark Q3 results: Net profit up 30% at Rs 248 crConsolidated revenue of the company stood at Rs 2,786.76 crore for the quarter under consideration. It was Rs 2,735.56 crore crore for the ...
- Glenmark Pharma surges 7% as Q1 net profit doubles to Rs 254 croreConsolidated revenue stood at Rs 2,344.78 crore for the first quarter compared with Rs 2,322.87 crore in the year-ago period, Glenmark Phar...
- Glenmark Q3 profit zooms 64% to Rs 191 crore; firm to raise $400 millionRevenue stood at Rs 2,735.56 crore against Rs 2,555.04 crore last year.
- Glenmark Q3 profit up 11% to Rs 116 croreConsolidated revenue stood at Rs 2,555.04 crore against Rs 2,203.66 crore in the year-ago period.
- Glenmark eyes 15% sales growth over 3-5 yearsGlenmark is targeting a consolidated revenue growth of 12-15 per cent over the next 3-5 years.
- Glenmark gets USFDA's tentative nod for Saxagliptin tabletsAccording to IMS Health sales data for the 12-month period ending April 2017, the Onglyza tablets, 2.5 mg and 5 mg market achieved annual s...
- Glenmark gets USFDA nod for Xylocaine ointmentThe approval given by the US Food & Drug Administration (USFDA) to Glenmark Pharmaceuticals Inc USA (Glenmark) is for Lidocaine Ointment US...
- Glenmark Q1 net profit up 3.29 per cent at Rs 190 croreGlenmark Pharmaceuticals posted 3.29 per cent rise in consolidated net profit at Rs 190.93 crore, driven by sales in domestic as well as ov...
- Glenmark gets tentative USFDA nod to sell RufinamideGlenmark Pharmaceuticals today said it has been granted tentative approval by the US health regulator to sell Rufinamide.
- Glenmark's anti-diabetes drugs shake up Indian anti-diabetes marketThe company has raked in Rs 16 crore in just 8 months since drug was launched.
- Glenmark Q3 net up 5-fold at Rs 213 cr due to strong salesGlenmark Pharmaceuticals today reported nearly five-fold jump in consolidated net profit at Rs 212.91 crore for its third quarter ended Dec...
- Glenmark Pharmaceuticals Q2 net up nearly three fold at Rs 156.75 crGlenmark Pharmaceuticals today said its consolidated net profit rose by nearly three fold to Rs 156.75 crore for the quarter ended Septembe...
- Glenmark Pharmaceuticals may be rerated due to attractive valuations, strong performanceAided by robust growth from its key businesses and geographies, Glenmark managed to show a strong topline growth of 34% year-on-year in the...
- Glenmark Pharma Q3 net nearly halvesDrugmaker Glenmark Pharmaceuticals Ltd's quarterly profit nearly halved on heavy foreign exchange losses from overseas borrowings despite r...
- Glenmark Q1 jumps nearly three-fold to Rs 155 cr on good salesGlenmark Pharmaceuticals on Tuesday reported nearly three-fold jump in consolidated net profit at Rs 155.54 crore for the first quarter end...
- Glenmark buys 7 Polish brands from ActavisGlenmark Pharmaceuticals on Wednesday said its European arm, Medicamenta, has acquired seven pharmaceutical brands from Iceland-based gener...
Load More
